Top Story

Light-scattering tool may improve early identification of pancreatic cancer

Light-scattering tool may improve early identification of pancreatic cancer
May 30, 2017

Researchers at the Center for Advanced Biomedical Imaging and Photonics at Beth Israel Deaconess Medical Center developed a novel tool designed to distinguish between benign pancreatic cysts and those that have the potential to transform into pancreatic cancer.

The device uses light-scattering spectroscopy to detect structural changes that occur in malignant or precancerous cells by bouncing light off tissues and analyzing the reflected spectrum.

In the Journals Plus

Decline in cervical lesions driven by HPV vaccination

May 28, 2017
Age and cohort patterns seen in recent data showed that declines in high-grade cervical lesions among young women are likely driven by HPV vaccination, not changes in…

Loyola Medicine appoints vice chair in radiation oncology department

May 28, 2017
Raymond B. Wynn, MD, FACR, has been appointed vice chair of network operations in the department of radiation oncology at Loyola Medicine. Wynn — who also will…

Dana-Farber Cancer Institute appoints gastrointestinal cancer center director

May 27, 2017
Brian Wolpin , MD, MPH, has been appointed director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute. Wolpin is chair in pancreatic…
FDA News

FDA expands approval of Zykadia for ALK–positive metastatic NSCLC

May 26, 2017
The FDA expanded the approval of ceritinib to include the first-line treatment of patients with metastatic non–small cell lung cancer, according to the…
More News Headlines »

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Meeting News

VIDEO: Speaker offers updates in cutaneous squamous cell carcinoma

April 16, 2017
More »
ASCO Annual Meeting

ASCO Annual Meeting


Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Current Issues
View the Current Issue
HemOnc Today